Related Experiment Video
Updated: May 27, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
EBHOA-EMobileNetV2: a hybrid system based on efficient feature selection and classification for cardiovascular
Manjula Mandava1, Surendra Reddy Vinta1
1School of Computer Science and Engineering, VIT-AP University, Amaravati, Andhra Pradesh, India.
Insights
This study introduces an intelligent healthcare framework using deep learning for accurate cardiovascular disease (CVD) prediction. The novel approach significantly improves detection accuracy, aiding early intervention and patient care.
Area of Science:
- Medical Informatics
- Artificial Intelligence
- Biomedical Engineering
Background:
- Accurate cardiovascular disease (CVD) prediction is crucial for timely patient treatment and preventing heart attacks.
- Existing deep learning and machine learning frameworks often lack data recognition and appropriate methodologies, hindering prediction accuracy.
- Intelligent healthcare systems require robust models for effective CVD detection.
Purpose of the Study:
- To develop an intelligent healthcare framework utilizing a deep learning model for enhanced cardiovascular disease prediction.
- To address limitations in existing methodologies by improving data quality and employing advanced feature selection and classification techniques.
- To provide a more accurate and consistent tool for heart disease prediction in clinical practice.
Main Methods:
- Data compilation from public sources (UCI Heart Disease, Framingham Heart Study).
- Data pre-processing: Interquartile Range (IQR) for outlier removal, data standardization for missing values, K-Means SMOTE for class imbalance.
- Feature selection using Enhanced Binary Grasshopper Optimization Algorithm (EBHOA) and prediction via Enhanced MobileNetV2 (EMobileNetV2) model.
Main Results:
- Achieved high accuracy: 98.78% on UCI Heart Disease dataset and 99.39% on Framingham dataset.
- Demonstrated superior performance metrics: precision (99-99.50%), recall (99-99.50%), and F1 score (99-99.50%).
- Outperformed current state-of-the-art methods in CVD prediction accuracy and consistency.
Conclusions:
- The proposed deep learning framework with EBHOA feature selection and EMobileNetV2 classification significantly enhances heart disease prediction accuracy.
- This innovative approach offers a valuable tool for improving clinical practice and patient care through more reliable CVD detection.
- The study highlights the potential of integrated AI techniques in advancing intelligent healthcare systems for cardiovascular health.
Abstract:
The accurate prediction of cardiovascular disease (CVD) or heart disease is an essential and challenging task to treat a patient efficiently before occurring a heart attack. Many deep learning and machine learning frameworks have been developed recently to predict cardiovascular disease in intelligent healthcare. However, a lack of data-recognized and appropriate prediction methodologies meant that most existing strategies failed to improve cardiovascular disease prediction accuracy. This paper presents an intelligent healthcare framework based on a deep learning model to detect cardiovascular heart disease, motivated by present issues. Initially, the proposed system compiles data on heart disease from multiple publicly accessible data sources. To improve the quality of the dataset, effective pre-processing techniques are used including (i) the interquartile range (IQR) method used to identify and eliminate outliers; (ii) the data standardization technique used to handle missing values; (iii) and the 'K-Means SMOTE' oversampling method is used to address the issue of class imbalance. Using the Enhanced Binary Grasshopper Optimization Algorithm (EBHOA), the dataset's appropriate features are chosen. Finally, the presence and absence of CVD are predicted using the Enhanced MobileNetV2 (EMobileNetV2) model. Training and evaluation of the proposed approach were conducted using the UCI Heart Disease and Framingham Heart Study datasets. We obtained excellent results by comparing the results with the most recent methods. The proposed approach beats the current approaches concerning performance evaluation metrics, according to experimental results. For the UCI Heart Disease dataset, the proposed research achieves a higher accuracy of 98.78%, precision of 99%, recall of 99% and F1 score of 99%. For the Framingham dataset, the proposed research achieves a higher accuracy of 99.39%, precision of 99.50%, recall of 99.50%, and F1 score of 99%. The proposed deep learning-based classification model combined with an effective feature selection technique yielded the best results. This innovative method has the potential to enhance the accuracy and consistency of heart disease prediction, which would be advantageous for clinical practice and patient care.
Related Concept Videos
Cardiovascular Drugs: Classification based on Therapeutic Indications
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...

